Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	pox	qox	pox_cutoff	isArtifactMode	oxoGCut
ACD	65057	broad.mit.edu	37	16	67692859	67692859	+	Missense_Mutation	SNP	T	T	C			TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chr16:67692859T>C	ENST00000219251.8	-	7	1197	c.866A>G	c.(865-867)cAc>cGc	p.H289R	ACD_ENST00000393919.4_Missense_Mutation_p.H292R	NM_001082486.1|NM_001082487.1|NM_022914.2	NP_001075955.1|NP_001075956.1|NP_075065.2	Q96AP0	ACD_HUMAN	adrenocortical dysplasia homolog (mouse)	292	Interaction with POT1.				intracellular protein transport|negative regulation of telomere maintenance via telomerase|positive regulation of single-stranded telomeric DNA binding|positive regulation of telomerase activity|protection from non-homologous end joining at telomere|protein localization to chromosome, telomeric region|telomere assembly	nuclear telomere cap complex|nucleoplasm	DNA binding|DNA polymerase binding			endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(1)|lung(5)|ovary(1)|pancreas(1)|skin(3)|upper_aerodigestive_tract(1)|urinary_tract(2)	17		Acute lymphoblastic leukemia(13;3.76e-06)|all_hematologic(13;0.000303)|Ovarian(137;0.0563)		OV - Ovarian serous cystadenocarcinoma(108;0.0143)|Epithelial(162;0.047)|all cancers(182;0.228)		GGCAGCCCAGTGGGTGACAGG	0.607000													16	75					0	0	0.038395	0	0
ZNF117	51351	broad.mit.edu	37	7	64438817	64438817	+	Missense_Mutation	SNP	T	T	C			TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chr7:64438817T>C	ENST00000282869.5	-	4	2416	c.1132A>G	c.(1132-1134)Aca>Gca	p.T378A		NM_015852.3	NP_056936.2	Q03924	ZN117_HUMAN	zinc finger protein 117	378						nucleus	DNA binding|sequence-specific DNA binding transcription factor activity|zinc ion binding			breast(1)|central_nervous_system(2)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(7)|liver(1)|lung(6)|prostate(1)|skin(1)	22		Lung NSC(55;0.0295)|all_lung(88;0.0691)				ATCTTATGTGTATTAAGGGCT	0.383000													7	53					0	0	0.038147	0	0
HRH2	0	broad.mit.edu	37	5	175110700	175110700	+	Missense_Mutation	SNP	A	A	T			TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chr5:175110700A>T	ENST00000231683.2	+	1	2237	c.464A>T	c.(463-465)cAc>cTc	p.H155L	HRH2_ENST00000377291.2_Missense_Mutation_p.H155L	NM_022304.2	NP_071640.1	P25021	HRH2_HUMAN	histamine receptor H2	155					G-protein signaling, coupled to cyclic nucleotide second messenger|immune response	integral to plasma membrane	histamine receptor activity			breast(1)|cervix(1)|endometrium(3)|large_intestine(6)|lung(10)|ovary(1)	22	all_cancers(89;0.00805)|Renal(175;0.000269)|Lung NSC(126;0.00419)|all_lung(126;0.00711)	Medulloblastoma(196;0.0208)|all_neural(177;0.0277)|all_hematologic(541;0.214)	Kidney(164;3.85e-05)|KIRC - Kidney renal clear cell carcinoma(164;0.000183)	Colorectal(1;0.0154)|COAD - Colon adenocarcinoma(1;0.149)	Betazole(DB00272)|Cimetidine(DB00501)|Doxepin(DB01142)|Epinastine(DB00751)|Famotidine(DB00927)|Histamine Phosphate(DB00667)|Nizatidine(DB00585)|Ranitidine(DB00863)	CTGTCTATCCACCTGGGGTGG	0.552000													9	58					0	0	0.069234	0	0
NAB2	4665	broad.mit.edu	37	12	57485457	57485457	+	Silent	SNP	T	T	C			TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chr12:57485457T>C	ENST00000300131.3	+	2	1011	c.633T>C	c.(631-633)ccT>ccC	p.P211P	NAB2_ENST00000554718.1_3'UTR|NAB2_ENST00000357680.4_Silent_p.P211P|NAB2_ENST00000342556.6_Silent_p.P211P	NM_005967.3	NP_005958.1	Q15742	NAB2_HUMAN	NGFI-A binding protein 2 (EGR1 binding protein 2)	211					cell proliferation|negative regulation of transcription from RNA polymerase III promoter|transcription, DNA-dependent	nucleus	transcription corepressor activity	p.P211P(3)		breast(1)|central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(6)|lung(5)|ovary(1)|prostate(2)|stomach(1)|upper_aerodigestive_tract(1)	20						TCTCCCCCCCTGCAGGGGGAG	0.711000													6	32					0	0	0.047766	0	0
MT-CYB	4519	broad.mit.edu	37	MT	15135	15135	+	Missense_Mutation	SNP	G	G	A			TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chrM:15135G>A	ENST00000361789.2	+	1	389	c.389G>A	c.(388-390)gGc>gAc	p.130_130insD						mitochondrially encoded cytochrome b											breast(6)|endometrium(25)|kidney(33)|prostate(1)	65						AGCCTTCATAGGCTATGTCCT	0.463000											OREG0007583	type=REGULATORY REGION|TFbs=ESR1|Dataset=Estrogen Receptor Alpha Binding Sites|EvidenceSubtype=Chromatin immunoprecipitation with tag sequencing (ChIP-TS)	5	230					0	0	0.014758	0	0
LL22NC03-80A10.6	0	broad.mit.edu	37	22	22664186	22664186	+	RNA	SNP	A	A	G			TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chr22:22664186A>G	ENST00000426066.1	+	0	709					NR_027293.1																						CAGATCAAGAAAGCACTCTGA	0.498000													3	65					0	0	0.009096	0	0
LL22NC03-80A10.6	0	broad.mit.edu	37	22	22663087	22663087	+	RNA	SNP	A	A	G	rs1054158		TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chr22:22663087A>G	ENST00000426066.1	+	0	526					NR_027293.1																						GCTGCCACATAAGTTGTCCTT	0.303000													3	36					0	0	0.009096	0	0
ABL2	27	broad.mit.edu	37	1	179112141	179112141	+	Silent	SNP	A	A	G			TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chr1:179112141A>G	ENST00000408940.3	-	1	38	c.39T>C	c.(37-39)taT>taC	p.Y13Y	ABL2_ENST00000511413.1_Intron|ABL2_ENST00000344730.3_Silent_p.Y13Y|ABL2_ENST00000507173.1_Intron|ABL2_ENST00000502732.1_Intron|ABL2_ENST00000512653.1_Silent_p.Y13Y|ABL2_ENST00000504405.1_Silent_p.Y13Y|ABL2_ENST00000367623.4_Intron|ABL2_ENST00000392043.3_Intron	NM_001168239.1	NP_001161711.1	P42684	ABL2_HUMAN	c-abl oncogene 2, non-receptor tyrosine kinase	0	CAP.				axon guidance|cell adhesion|peptidyl-tyrosine phosphorylation|positive regulation of oxidoreductase activity|signal transduction	cytoskeleton|cytosol	ATP binding|magnesium ion binding|manganese ion binding|non-membrane spanning protein tyrosine kinase activity|protein binding			breast(8)|central_nervous_system(1)|endometrium(7)|kidney(1)|large_intestine(9)|lung(32)|ovary(3)|prostate(2)|skin(1)|upper_aerodigestive_tract(1)	65					Adenosine triphosphate(DB00171)|Dasatinib(DB01254)	GATCTCTGCCATAACTATTAG	0.458000			T	ETV6	AML								7	54					0	0	0.047766	0	0
TSSC2	0	broad.mit.edu	37	11	3427759	3427759	+	RNA	SNP	C	C	T			TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chr11:3427759C>T	ENST00000529482.1	+	0	876																											TGTCTGCACACGTCCTGCAGT	0.612000													4	52					0	0	0.009096	0	0
CHEK2	11200	broad.mit.edu	37	22	29091841	29091841	+	Silent	SNP	G	G	A	rs146546850	byFrequency	TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chr22:29091841G>A	ENST00000544772.1	-	12	1889	c.453C>T	c.(451-453)tcC>tcT	p.S151S	CHEK2_ENST00000382566.1_3'UTR|CHEK2_ENST00000404276.1_Silent_p.S372S|CHEK2_ENST00000328354.6_Silent_p.S372S|CHEK2_ENST00000405598.1_Silent_p.S372S|CHEK2_ENST00000348295.3_Silent_p.S343S|CHEK2_ENST00000382580.2_Silent_p.S415S|CHEK2_ENST00000382578.1_Silent_p.S281S|CHEK2_ENST00000402731.1_Silent_p.S343S|CHEK2_ENST00000403642.1_Silent_p.S281S|CHEK2_ENST00000382565.1_Intron	NM_001257387.1	NP_001244316.1	O96017	CHK2_HUMAN	checkpoint kinase 2	372	FHA.				cell cycle|DNA damage checkpoint|DNA damage response, signal transduction resulting in induction of apoptosis|replicative senescence	PML body	ATP binding|metal ion binding|protein binding|protein serine/threonine kinase activity	p.S372S(8)		central_nervous_system(17)|endometrium(2)|kidney(11)|large_intestine(2)|lung(11)|ovary(1)|prostate(4)|stomach(2)	50						CCAAAATCTTGGAGTGCCCAA	0.413000			F			breast		Direct reversal of damage;Other conserved DNA damage response genes					4	58					0	0	0.038147	0	0
ANKRD30A	91074	broad.mit.edu	37	10	37454025	37454025	+	Missense_Mutation	SNP	A	A	T			TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chr10:37454025A>T	ENST00000374660.1	+	18	1937	c.1838A>T	c.(1837-1839)gAg>gTg	p.E613V	ANKRD30A_ENST00000361713.1_Missense_Mutation_p.E613V|ANKRD30A_ENST00000602533.1_Missense_Mutation_p.E613V			Q9BXX3	AN30A_HUMAN	ankyrin repeat domain 30A	669						nucleus	DNA binding|sequence-specific DNA binding transcription factor activity			NS(1)|breast(8)|endometrium(14)|kidney(21)|large_intestine(13)|lung(70)|ovary(8)|pancreas(1)|prostate(3)|skin(15)|stomach(1)|urinary_tract(3)	158						TTTATAGATGAGATACTCCCA	0.308000													6	48					0	0	0.038147	0	0
ITGAX	3687	broad.mit.edu	37	16	31374648	31374648	+	Silent	SNP	C	C	T			TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chr16:31374648C>T	ENST00000268296.4	+	14	1784	c.1663C>T	c.(1663-1665)Ctg>Ttg	p.L555L	ITGAX_ENST00000562522.1_Silent_p.L555L	NM_000887.3	NP_000878.2	P20702	ITAX_HUMAN	integrin, alpha X (complement component 3 receptor 4 subunit)	555					blood coagulation|cell adhesion|integrin-mediated signaling pathway|leukocyte migration|organ morphogenesis	integrin complex	protein binding|receptor activity			NS(1)|breast(1)|central_nervous_system(1)|endometrium(11)|haematopoietic_and_lymphoid_tissue(2)|kidney(3)|large_intestine(8)|lung(42)|ovary(2)|pancreas(1)|prostate(1)|skin(3)|upper_aerodigestive_tract(1)	77						TGCTGTCTACCTGTTTCACGG	0.622000													38	115					0	0	0.086207	0	0
MT-RNR2	0	broad.mit.edu	37	MT	3022	3022	+	RNA	SNP	G	G	A			TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chrM:3022G>A	ENST00000387347.2	+	0	1352					NR_039705.1																						GATGGTGCAGCCGCTATTAAA	0.453000													7	217					0	0	0.047766	0	0
MT-ND5	4540	broad.mit.edu	37	MT	12591	12591	+	Missense_Mutation	SNP	C	C	A			TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chrM:12591C>A	ENST00000361567.2	+	1	255	c.255C>A	c.(253-255)ttC>ttA	p.F85L				P03915	NU5M_HUMAN	mitochondrially encoded NADH dehydrogenase 5	85					mitochondrial electron transport, NADH to ubiquinone|transport	integral to membrane|mitochondrial respiratory chain complex I	NADH dehydrogenase (ubiquinone) activity			breast(4)|endometrium(29)|kidney(33)|pancreas(1)|prostate(7)	74					NADH(DB00157)	CTAGACTACTTCTCCATAATA	0.393000													10	190					6.42651e-13	1.08082e-12	0.080935	1	0
CHUK	1147	broad.mit.edu	37	10	101953150	101953150	+	Silent	SNP	T	T	C			TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chr10:101953150T>C	ENST00000370397.7	-	19	2099	c.2013A>G	c.(2011-2013)ctA>ctG	p.L671L	CHUK_ENST00000590930.1_5'UTR	NM_001278.3	NP_001269.3	O15111	IKKA_HUMAN	conserved helix-loop-helix ubiquitous kinase	671					I-kappaB phosphorylation|innate immune response|MyD88-dependent toll-like receptor signaling pathway|MyD88-independent toll-like receptor signaling pathway|nerve growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|positive regulation of I-kappaB kinase/NF-kappaB cascade|positive regulation of NF-kappaB transcription factor activity|T cell receptor signaling pathway|Toll signaling pathway|toll-like receptor 1 signaling pathway|toll-like receptor 2 signaling pathway|toll-like receptor 3 signaling pathway|toll-like receptor 4 signaling pathway	CD40 receptor complex|cytosol|internal side of plasma membrane|nucleus	ATP binding|identical protein binding|IkappaB kinase activity			breast(1)|central_nervous_system(2)|endometrium(2)|large_intestine(9)|lung(8)|ovary(2)|prostate(1)|skin(1)|stomach(1)	27		Colorectal(252;0.117)		Epithelial(162;2.05e-10)|all cancers(201;1.91e-08)		CTGCACCTTCTAGACTGGATC	0.473000													22	51					0	0	0.076483	0	0
MT-CO1	4512	broad.mit.edu	37	MT	6718	6718	+	Missense_Mutation	SNP	G	G	A			TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chrM:6718G>A	ENST00000361624.2	+	1	815	c.815G>A	c.(814-816)gGt>gAt	p.272_272insD						mitochondrially encoded cytochrome c oxidase I											breast(4)|endometrium(25)|kidney(19)|lung(3)|prostate(3)	54						TGGATACATAGGTATGGTCTG	0.393000													60	60					0	0	0.048971	0	0
CHEK2	11200	broad.mit.edu	37	22	29091840	29091840	+	Missense_Mutation	SNP	T	T	C	rs142470496	byFrequency	TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chr22:29091840T>C	ENST00000544772.1	-	12	1890	c.454A>G	c.(454-456)Aag>Gag	p.K152E	CHEK2_ENST00000382566.1_3'UTR|CHEK2_ENST00000404276.1_Missense_Mutation_p.K373E|CHEK2_ENST00000328354.6_Missense_Mutation_p.K373E|CHEK2_ENST00000405598.1_Missense_Mutation_p.K373E|CHEK2_ENST00000348295.3_Missense_Mutation_p.K344E|CHEK2_ENST00000382580.2_Missense_Mutation_p.K416E|CHEK2_ENST00000382578.1_Missense_Mutation_p.K282E|CHEK2_ENST00000402731.1_Missense_Mutation_p.K344E|CHEK2_ENST00000403642.1_Missense_Mutation_p.K282E|CHEK2_ENST00000382565.1_Intron	NM_001257387.1	NP_001244316.1	O96017	CHK2_HUMAN	checkpoint kinase 2	373	FHA.				cell cycle|DNA damage checkpoint|DNA damage response, signal transduction resulting in induction of apoptosis|replicative senescence	PML body	ATP binding|metal ion binding|protein binding|protein serine/threonine kinase activity	p.K373E(9)		central_nervous_system(17)|endometrium(2)|kidney(11)|large_intestine(2)|lung(11)|ovary(1)|prostate(4)|stomach(2)	50						CCCAAAATCTTGGAGTGCCCA	0.418000			F			breast		Direct reversal of damage;Other conserved DNA damage response genes					3	60					0	0	0.038147	0	0
JAK2	3717	broad.mit.edu	37	9	5029859	5029859	+	Silent	SNP	C	C	T			TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chr9:5029859C>T	ENST00000381652.3	+	4	797	c.303C>T	c.(301-303)gtC>gtT	p.V101V	JAK2_ENST00000539801.1_Silent_p.V101V	NM_004972.3	NP_004963.1	O60674	JAK2_HUMAN	Janus kinase 2	101	FERM.|Interaction with cytokine/interferon/growth hormone receptors (By similarity).				actin filament polymerization|activation of caspase activity by protein phosphorylation|activation of JAK2 kinase activity|blood coagulation|cellular component movement|erythrocyte differentiation|interferon-gamma-mediated signaling pathway|interleukin-12-mediated signaling pathway|JAK-STAT cascade involved in growth hormone signaling pathway|mammary gland epithelium development|mesoderm development|negative regulation of cell proliferation|negative regulation of DNA binding|positive regulation of apoptosis|positive regulation of cell-substrate adhesion|positive regulation of growth hormone receptor signaling pathway|positive regulation of nitric-oxide synthase 2 biosynthetic process|positive regulation of phosphatidylinositol 3-kinase cascade|positive regulation of tumor necrosis factor production|positive regulation of tyrosine phosphorylation of Stat3 protein|positive regulation of tyrosine phosphorylation of Stat5 protein|protein autophosphorylation|regulation of inflammatory response|regulation of interferon-gamma-mediated signaling pathway|response to antibiotic|response to lipopolysaccharide|STAT protein import into nucleus|tumor necrosis factor-mediated signaling pathway|tyrosine phosphorylation of STAT protein	caveola|cytoskeleton|cytosol|endomembrane system|nucleus	ATP binding|growth hormone receptor binding|heme binding|histone binding|histone kinase activity (H3-Y41 specific)|interleukin-12 receptor binding|non-membrane spanning protein tyrosine kinase activity|protein kinase binding|SH2 domain binding		BCR/JAK2(6)|SSBP2/JAK2(4)|SEC31A/JAK2(4)|ETV6/JAK2(11)|PCM1/JAK2(30)|PAX5/JAK2(18)	breast(5)|endometrium(4)|haematopoietic_and_lymphoid_tissue(32944)|kidney(4)|large_intestine(10)|liver(1)|lung(20)|ovary(3)|prostate(4)|skin(2)|urinary_tract(1)	32998	all_hematologic(13;0.137)	Acute lymphoblastic leukemia(23;0.0198)|Breast(48;0.147)		GBM - Glioblastoma multiforme(50;0.0237)|Lung(218;0.133)		CCAACCATGTCTTCCATATAG	0.368000		1	"""T, Mis, O"""	"""ETV6, PCM1, BCR"""	"""ALL, AML, MPD,  CML"""				Polycythemia Vera, Familial				16	99					0	0	0.033300	0	0
BRAF	673	broad.mit.edu	37	7	140453136	140453136	+	Missense_Mutation	SNP	A	A	T	rs121913377		TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chr7:140453136A>T	ENST00000288602.6	-	15	1859	c.1799T>A	c.(1798-1800)gTg>gAg	p.V600E		NM_004333.4	NP_004324.2	P15056	BRAF_HUMAN	v-raf murine sarcoma viral oncogene homolog B	600	Protein kinase.		V -> D (in a melanoma cell line; requires 2 nucleotide substitutions).|V -> E (in sarcoma, colorectal adenocarcinoma, metastatic melanoma, ovarian serous carcinoma, pilocytic astrocytoma; somatic mutation; most common mutation; constitutive and elevated kinase activity; efficiently induces cell transformation; suppression of mutation in melanoma causes growth arrest and promotes apoptosis).		activation of MAPKK activity|anti-apoptosis|nerve growth factor receptor signaling pathway|organ morphogenesis|positive regulation of peptidyl-serine phosphorylation|small GTPase mediated signal transduction|synaptic transmission	cytosol|nucleus|plasma membrane	ATP binding|metal ion binding	p.V600E(15453)|p.V600K(252)|p.V600R(44)|p.V600D(16)|p.V600A(12)|p.V600_K601>E(12)|p.V600G(11)|p.T599_R603>I(2)|p.V600Q(2)|p.V600_S605>EK(1)|p.V600_S605>DV(1)|p.V600_S605>D(1)|p.T599_V600insDFGLAT(1)	SLC45A3/BRAF(2)|AGTRAP/BRAF(2)|FAM131B_ENST00000443739/BRAF(7)|AKAP9_ENST00000356239/BRAF(10)|KIAA1549/BRAF(703)|FCHSD1/BRAF(2)	NS(588)|adrenal_gland(3)|autonomic_ganglia(3)|biliary_tract(29)|bone(7)|breast(21)|central_nervous_system(99)|cervix(6)|endometrium(33)|eye(72)|gastrointestinal_tract_(site_indeterminate)(2)|genital_tract(4)|haematopoietic_and_lymphoid_tissue(436)|kidney(3)|large_intestine(6953)|liver(17)|lung(192)|oesophagus(4)|ovary(275)|pancreas(15)|pituitary(1)|prostate(25)|salivary_gland(1)|skin(6285)|small_intestine(12)|soft_tissue(40)|stomach(11)|testis(7)|thyroid(12220)|upper_aerodigestive_tract(13)|urinary_tract(3)	27380	Melanoma(164;0.00956)				Sorafenib(DB00398)	TCGAGATTTCACTGTAGCTAG	0.368000	V600D(K029AX_SKIN)|V600D(WM115_SKIN)|V600D(WM2664_SKIN)|V600E(8505C_THYROID)|V600E(A101D_SKIN)|V600E(A2058_SKIN)|V600E(A375_SKIN)|V600E(A673_BONE)|V600E(AM38_CENTRAL_NERVOUS_SYSTEM)|V600E(BCPAP_THYROID)|V600E(BHT101_THYROID)|V600E(BT474_BREAST)|V600E(C32_SKIN)|V600E(CL34_LARGE_INTESTINE)|V600E(COLO205_LARGE_INTESTINE)|V600E(COLO679_SKIN)|V600E(COLO741_SKIN)|V600E(COLO783_SKIN)|V600E(COLO800_SKIN)|V600E(COLO818_SKIN)|V600E(COLO829_SKIN)|V600E(COLO849_SKIN)|V600E(DBTRG05MG_CENTRAL_NERVOUS_SYSTEM)|V600E(DU4475_BREAST)|V600E(ES2_OVARY)|V600E(G361_SKIN)|V600E(GCT_SOFT_TISSUE)|V600E(HS294T_SKIN)|V600E(HS695T_SKIN)|V600E(HS939T_SKIN)|V600E(IGR1_SKIN)|V600E(IGR37_SKIN)|V600E(IGR39_SKIN)|V600E(K029AX_SKIN)|V600E(KG1C_CENTRAL_NERVOUS_SYSTEM)|V600E(LOXIMVI_SKIN)|V600E(MALME3M_SKIN)|V600E(MELHO_SKIN)|V600E(OUMS23_LARGE_INTESTINE)|V600E(RKO_LARGE_INTESTINE)|V600E(RPMI7951_SKIN)|V600E(RVH421_SKIN)|V600E(SH4_SKIN)|V600E(SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|V600E(SKHEP1_LIVER)|V600E(SKMEL24_SKIN)|V600E(SKMEL28_SKIN)|V600E(SKMEL5_SKIN)|V600E(SW1417_LARGE_INTESTINE)|V600E(UACC257_SKIN)|V600E(UACC62_SKIN)|V600E(WM793_SKIN)|V600E(WM88_SKIN)|V600E(WM983B_SKIN)	61	"""Mis, T, O"""	"""AKAP9, KIAA1549"""	"""melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma"""		Cardio-facio-cutaneous syndrome		Cardiofaciocutaneous syndrome				15	29					0	0	0.033300	0	0
MLF2	8079	broad.mit.edu	37	12	6859403	6859403	+	Silent	SNP	C	C	A			TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chr12:6859403C>A	ENST00000203630.5	-	6	983	c.339G>T	c.(337-339)acG>acT	p.T113T	MLF2_ENST00000542154.1_Silent_p.T113T|MLF2_ENST00000435120.1_Silent_p.T113T|MLF2_ENST00000539187.1_Silent_p.T113T			Q15773	MLF2_HUMAN	myeloid leukemia factor 2	113					defense response	cytoplasm|nucleus	protein binding	p.T113T(1)		kidney(2)|large_intestine(3)|lung(4)	9						CACCATCACCCGTATTGGAGT	0.567000													5	156					8.12818e-05	0.000130758	0.029380	1	0
ESPNP	0	broad.mit.edu	37	1	17034125	17034126	+	RNA	INS	-	-	AGCT	rs141324796	by1000genomes	TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chr1:17034125_17034126insAGCT	ENST00000492551.1	-	0	477_478					NR_026567.1																						CAGCAGCAGCCAGCTGAGCACC	0.718													8	10	---	---	---	---					
RP11-73M7.1	0	broad.mit.edu	37	1	32041150	32041150	+	RNA	DEL	G	G	-			TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chr1:32041150delG	ENST00000435872.1	-	0	24																											GGAGGGCAAAGGGAGTCCCTG	0.622													2	4	---	---	---	---					
RP11-608O21.1	0	broad.mit.edu	37	4	19815894	19815895	+	RNA	INS	-	-	A	rs145239076		TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chr4:19815894_19815895insA	ENST00000511431.1	+	0	288																											CTCTGGGCTGTaaaaaaaaaaa	0.416													2	4	---	---	---	---					
Z84812.4	0	broad.mit.edu	37	16	84036	84053	+	RNA	DEL	GGGAGCCTGGAAGCACAC	GGGAGCCTGGAAGCACAC	-	rs3743872	by1000genomes	TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chr16:84036_84053delGGGAGCCTGGAAGCACAC	ENST00000568710.1	-	0	349																											CTTGTCTCTGGGGAGCCTGGAAGCACACGGGCTGGCTA	0.633													4	5	---	---	---	---					
LINC00854	0	broad.mit.edu	37	17	41381669	41381670	+	RNA	INS	-	-	C	rs111303145		TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chr17:41381669_41381670insC	ENST00000433702.2	-	0	14					NR_047479.1																						agaggctgaggcaggagggtgg	0.564													5	4	---	---	---	---					
RP11-53I6.2	0	broad.mit.edu	37	18	29656288	29656288	+	RNA	DEL	T	T	-			TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chr18:29656288delT	ENST00000583184.1	+	0	539																											tgtttttttgttttttttttg	0.438													2	4	---	---	---	---					
AC008984.2	0	broad.mit.edu	37	19	54843564	54843565	+	RNA	INS	-	-	C	rs144647366	by1000genomes	TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chr19:54843564_54843565insC	ENST00000507363.1	-	0	430																											CGGCTGCTCCTCCCCAGGCTGC	0.723													3	4	---	---	---	---					
BAGE2	85319	broad.mit.edu	37	21	11068910	11068911	+	RNA	DEL	AT	AT	-	rs147061174		TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chr21:11068910_11068911delAT	ENST00000470054.1	-	0	324									B melanoma antigen family, member 2															Colorectal(6;3.44e-05)|COAD - Colon adenocarcinoma(6;0.00727)|READ - Rectum adenocarcinoma(6;0.0723)	UCEC - Uterine corpus endometrioid carcinoma (6;0.0974)|all cancers(6;2.54e-22)|Epithelial(6;4.21e-19)|OV - Ovarian serous cystadenocarcinoma(6;1.16e-09)|BRCA - Breast invasive adenocarcinoma(6;7.72e-05)|Lung(8;0.000189)|LUSC - Lung squamous cell carcinoma(6;0.00379)|GBM - Glioblastoma multiforme(6;0.00391)|Kidney(17;0.0773)|LUAD - Lung adenocarcinoma(8;0.247)		ttctcttatcatatgtgtaatt	0.282													3	4	---	---	---	---					
AP003900.6	0	broad.mit.edu	37	21	11180762	11180762	+	RNA	DEL	T	T	-	rs146742149		TCGA-EM-A2OX-01A-11D-A202-08	TCGA-EM-A2OX-10A-01D-A202-08								Untested	Somatic	Phase_I	WXS	none			Illumina GAIIx	474b66e6-0202-43b6-8806-d0470074c286	73556664-4b53-4e6b-94c7-28f1061cf074	g.chr21:11180762delT	ENST00000603265.1	+	0	231																											aACTAACTTCTTTTTTTTTTT	0.348													4	8	---	---	---	---					
